Evaluation of the Anti-Histoplasma capsulatum Activity of Indole and Nitrofuran Derivatives and Their Pharmacological Safety in Three-Dimensional Cell Cultures
Vaso, C.O.; Bila, N.M.; Pandolfi, F.; De Vita, D.; Bortolami, M.; Bonatti, J.L.C.; De Moraes Silva, R.A.; Gonçalves, L.N.C.; Tudino, V.; Costi, R.; Di Santo, R.; Mendes-Giannini, M.J.S.; Costa-Orlandi, C.B.; Scipione, L.; Fusco-Almeida, A.M. Evaluation of the Anti-Histoplasma capsulatum Activity of Indole and Nitrofuran Derivatives and Their Pharmacological Safety in Three-Dimensional Cell Cultures. Pharmaceutics 2022, 14, 1043. https://doi.org/10.3390/pharmaceutics14051043
Vaso CO, Bila NM, Pandolfi F, De Vita D, Bortolami M, Bonatti JLC, De Moraes Silva RA, Gonçalves LNC, Tudino V, Costi R, Di Santo R, Mendes-Giannini MJS, Costa-Orlandi CB, Scipione L, Fusco-Almeida AM. Evaluation of the Anti-Histoplasma capsulatum Activity of Indole and Nitrofuran Derivatives and Their Pharmacological Safety in Three-Dimensional Cell Cultures. Pharmaceutics. 2022; 14(5):1043. https://doi.org/10.3390/pharmaceutics14051043
Chicago/Turabian StyleVaso, Carolina O., Níura M. Bila, Fabiana Pandolfi, Daniela De Vita, Martina Bortolami, Jean L.C. Bonatti, Rosângela A. De Moraes Silva, Larissa N.C. Gonçalves, Valeria Tudino, Roberta Costi, Roberto Di Santo, Maria J.S. Mendes-Giannini, Caroline B. Costa-Orlandi, Luigi Scipione, and Ana M. Fusco-Almeida. 2022. "Evaluation of the Anti-Histoplasma capsulatum Activity of Indole and Nitrofuran Derivatives and Their Pharmacological Safety in Three-Dimensional Cell Cultures" Pharmaceutics 14, no. 5: 1043. https://doi.org/10.3390/pharmaceutics14051043